
Core Viewpoint - Biote Corp. (BTMD) has seen a 27% increase in share price over the past four weeks, closing at $6.63, with analysts suggesting a potential upside of 43.9% based on a mean price target of $9.54 [1] Price Targets - The average price target consists of five estimates ranging from $8 to $11, with a standard deviation of $1.12, indicating a potential increase of 20.7% to 65.9% from the current price [2] - A low standard deviation suggests a strong agreement among analysts regarding the price targets, which can be a useful starting point for further research [7] Analyst Sentiment - Analysts show strong agreement in revising earnings estimates higher for BTMD, which correlates with potential stock price increases [9] - The Zacks Consensus Estimate for the current year has risen by 44.8% over the past month, with two estimates increasing and no negative revisions [10] Zacks Rank - BTMD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential upside [11] Caution on Price Targets - While price targets are a common metric, they should be approached with skepticism as they may not reliably indicate actual stock price movements [5][8]